FLUID-02-NC: Percentage of non-cardiac cases in which colloids were not administered intraoperatively.

FLUID-02-C: Percentage of cardiac cases in which colloids were not administered intraoperatively.

There is a lack of consistent evidence to suggest improved survival with the use of colloids as compared to crystalloids in the surgical population. Because colloids are more expensive than crystalloids, it is recommended that anesthesia providers avoid the use of colloids in most instances.

Patient In Room to Patient out of Room

FLUID-02-NC: Patients < 18y who undergo a non-cardiac procedure

FLUID-02-C: Patients < 18y who undergo an open cardiac procedure (as defined by the MPOG Cardiac phenotype)

• Patients ≥ 18 years of age
• ASA 5 & 6
• Massive Transfusion or blood loss: Defined as volume of 40mL/kg
• Procedure Type: Non-operative
• Patients that are in prone or trendelenburg position for ≥ 4 hours
• Patients with ascites

Colloids are not administered during the case.

The provider signed in at the time of colloid administration

1. Bhardwaj N. Perioperative fluid therapy and intraoperative blood loss in children. Indian J Anaesth. 2019;63(9):729-736.
2. Sümpelmann R, Kretz FJ, Luntzer R, et al. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in 1130 children: results of an European prospective multicenter observational postauthorization safety study (PASS). Paediatr Anaesth. 2012;22(4):371-378.
3. Bailey AG, McNaull PP, Jooste E, Tuchman JB. Perioperative crystalloid and colloid fluid management in children: where are we and how did we get here? Anesth Analg. 2010;110(2):375-390.
4. Riegger LQ, Voepel-Lewis T, Kulik TJ, et al. Albumin versus crystalloid prime solution for cardiopulmonary bypass in young children. Crit Care Med. 2002;30(12):2649-2654.